---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-010858"
form_type: "8-K"
ticker: null
cik: "0001711933"
company_name: "Akoya Biosciences, Inc."
filed_at: "2024-08-05T23:59:59+00:00"
generated_at: "2026-05-31T13:09:44.419185+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Akoya Biosciences Q2 revenue $23.2M, up 26% sequentially; COO retiring; FY guidance $96-104M

## Summary
- Revenue $23.2M, up 26.2% sequentially from Q1 2024; YoY down 1.5% from $23.5M.
- Gross margin improved to 57.8% from 45.7% in Q1 2024 and 51.5% in Q2 2023.
- Operating loss narrowed to $11.1M from $21.6M in Q1 2024 and $19.2M in Q2 2023.
- Updated FY2024 revenue guidance $96-104M; reaffirms operating cash flow breakeven by year-end.
- COO Frederic Pla retiring effective August 16, 2024; will assist transition.

## SEC filing metadata
- accession: 0001558370-24-010858
- form_type: 8-K
- cik: 0001711933
- company_name: Akoya Biosciences, Inc.
- filed_at: 2024-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711933/000155837024010858/0001558370-24-010858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711933/000155837024010858/akya-20240731x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-010858
- JSON: https://secwatch.observer/filing/0001558370-24-010858.json
- Plain text: https://secwatch.observer/filing/0001558370-24-010858.txt

## Key facts
- Executive change
  Frederic Pla departed as Chief Operating Officer at Akoya Biosciences, Inc..
  - Action: retire
  - Role: Chief Operating Officer
  source text: On July 31, 2024, Frederic Pla notified the Company of his intent to retire from his position as Chief Operating Officer of the Company, effective August 16, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1711933/000155837024010858/0001558370-24-010858-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.